Neville Rodie & Shaw’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.54M | Sell |
21,415
-27,980
| -57% | -$2.63M | 0.1% | 109 |
|
|
2026
Q1 | $5.84M | Sell |
49,395
-17,710
| -26% | -$2.19M | 0.42% | 53 |
|
|
2025
Q4 | $8.44M | Sell |
67,105
-24,029
| -26% | -$3.13M | 0.6% | 43 |
|
|
2025
Q3 | $13.3M | Sell |
91,134
-25,149
| -22% | -$3.8M | 0.96% | 28 |
|
|
2025
Q2 | $18.1M | Sell |
116,283
-6,470
| -5% | -$1.03M | 1.35% | 20 |
|
|
2025
Q1 | $20.2M | Sell |
122,753
-3,634
| -3% | -$604K | 1.58% | 17 |
|
|
2024
Q4 | $20.6M | Sell |
126,387
-2,107
| -2% | -$377K | 1.5% | 17 |
|
|
2024
Q3 | $25.1M | Sell |
128,494
-3,772
| -3% | -$695K | 1.85% | 15 |
|
|
2024
Q2 | $22.9M | Sell |
132,266
-5,313
| -4% | -$884K | 1.74% | 15 |
|
|
2024
Q1 | $23.3M | Buy |
137,579
+2,910
| +2% | +$545K | 1.78% | 15 |
|
|
2023
Q4 | $26.6M | Sell |
134,669
-1,457
| -1% | -$258K | 2.17% | 9 |
|
|
2023
Q3 | $23.7M | Sell |
136,126
-843
| -0.6% | -$153K | 2.11% | 9 |
|
|
2023
Q2 | $23.6M | Buy |
136,969
+1,233
| +0.9% | +$213K | 2.03% | 10 |
|
|
2023
Q1 | $22.6M | Buy |
135,736
+2,288
| +2% | +$375K | 2.05% | 8 |
|
|
2022
Q4 | $19.6M | Sell |
133,448
-2,446
| -2% | -$362K | 1.84% | 13 |
|
|
2022
Q3 | $20.2M | Sell |
135,894
-760
| -0.6% | -$127K | 1.98% | 8 |
|
|
2022
Q2 | $23.5M | Sell |
136,654
-461
| -0.3% | -$79.7K | 2.1% | 7 |
|
|
2022
Q1 | $26.2M | Sell |
137,115
-2,322
| -2% | -$459K | 1.95% | 8 |
|
|
2021
Q4 | $34M | Sell |
139,437
-2,289
| -2% | -$501K | 2.41% | 7 |
|
|
2021
Q3 | $27.5M | Sell |
141,726
-2,233
| -2% | -$451K | 2.14% | 8 |
|
|
2021
Q2 | $26.8M | Sell |
143,959
-701
| -0.5% | -$122K | 2.07% | 8 |
|
|
2021
Q1 | $22.8M | Sell |
144,660
-2,932
| -2% | -$465K | 1.89% | 9 |
|
|
2020
Q4 | $24.4M | Sell |
147,592
-7,299
| -5% | -$1.19M | 2.12% | 8 |
|
|
2020
Q3 | $25.6M | Buy |
154,891
+1,307
| +0.9% | +$201K | 2.42% | 6 |
|
|
2020
Q2 | $21M | Buy |
153,584
+1,133
| +0.7% | +$148K | 2.17% | 8 |
|
|
2020
Q1 | $17.9M | Sell |
152,451
-958
| -0.6% | -$126K | 2.18% | 11 |
|
|
2019
Q4 | $20.3M | Buy |
153,409
+6,360
| +4% | +$790K | 1.99% | 12 |
|
|
2019
Q3 | $18.3M | Sell |
147,049
-2,856
| -2% | -$345K | 1.94% | 12 |
|
|
2019
Q2 | $17M | Sell |
149,905
-3,143
| -2% | -$329K | 1.8% | 12 |
|
|
2019
Q1 | $15.4M | Buy |
153,048
+2,278
| +2% | +$207K | 1.63% | 15 |
|
|
2018
Q4 | $12.9M | Sell |
150,770
-2,223
| -1% | -$200K | 1.56% | 16 |
|
|
2018
Q3 | $14M | Sell |
152,993
-1,494
| -1% | -$133K | 1.38% | 18 |
|
|
2018
Q2 | $13.2M | Buy |
154,487
+2,153
| +1% | +$182K | 1.39% | 19 |
|
|
2018
Q1 | $12.7M | Sell |
152,334
-2,572
| -2% | -$203K | 1.4% | 18 |
|
|
2017
Q4 | $11.2M | Buy |
154,906
+12,387
| +9% | +$851K | 1.18% | 27 |
|
|
2017
Q3 | $9.09M | Buy |
142,519
+1,953
| +1% | +$122K | 1.01% | 32 |
|
|
2017
Q2 | $8.77M | Buy |
140,566
+7,661
| +6% | +$452K | 1% | 32 |
|
|
2017
Q1 | $7.09M | Buy |
+132,905
| New | +$7.18M | 0.81% | 38 |
|
Other funds holding ZTS
BPC
MBI
ATO
SI
MIHAS
FFM
CIM
SIM
RC
Neville Rodie & Shaw's ZTS Position: Q2 2026 in Review
Neville Rodie & Shaw reduced its Zoetis (ZTS) stake by 57% in Q2 2026, selling an estimated $2.63M and leaving 21,415 shares worth $1.54M. The position accounts for 0.1% of the portfolio, ranked #109.
Neville Rodie & Shaw first reported a position in ZTS in Q1 2017 and has held it in 38 quarters since. The position peaked at $34M in Q4 2021. 480 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Neville Rodie & Shaw held 21,415 shares of Zoetis worth $1.54M as of Q2 2026.
- Neville Rodie & Shaw sold 27,980 Zoetis shares in Q2 2026, an estimated $2.63M.
- Zoetis made up 0.1% of Neville Rodie & Shaw's portfolio in Q2 2026, its #109 holding.
- Neville Rodie & Shaw first reported a position in Zoetis in Q1 2017 and has held it in 38 quarters since.
- Neville Rodie & Shaw's Zoetis position peaked at $34M in Q4 2021.
- 480 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.